Cancer is currently the leading cause of life years lost in the United States. Many forms of cancer that are easy to detect often go undiagnosed, are misdiagnosed, or are diagnosed too late, which leads to avoidable deaths and financial burdens. In “The Clinical and Economic Impact of the Early Detection and Diagnosis of Cancer,” Partner Richard Manning and his co-authors advocate for adoption of the early detection and diagnosis (EDD) method, which can increase early detection rates of cancer by teaching patients to self-assess and accurately describe their symptoms, which would then enable practitioners to make earlier and more accurate diagnoses. The authors analyze the EDD’s potential economic and clinical impact and the challenges associated with its adoption in the United States, and they propose legislative and regulatory solutions that promote EDD.
Richard Manning, Peter J. Deckers, Tricia Laursen, Stacey Worthy, and Shruti Kulkarni
Health Law & Policy Brief